Why your DNA might dictate which cancer drugs actually work
In short: Standard medicine often follows a one-size-fits-all approach, but your biology is unique. Personalized medicine moves away from this by using your specific genetic and genomic data to tailor treatments. By identifying the exact mutations driving a disease, doctors can choose therapies designed for your body alone.
Personalized medicine shifts the medical paradigm from general strategies to individual precision. While traditional medicine applies the same treatment across broad patient groups, this approach uses information derived from a person's genes and genome to make more informed decisions about prevention, diagnosis, and treatment. This field gained significant momentum in the 1990s following breakthroughs in DNA sequencing technology, such as the Human Genome Project (1990–2003), which mapped over three billion base pairs of human DNA.
The mechanism relies on various types of testing to identify unique biological markers. Genetic testing looks for specific mutations in individual genes, often to assess inherited risks within families. Genomic testing examines all the information in cancer DNA to see how cells differ from normal ones. Additionally, protein testing analyzes how cells perform their work—such as growing or reproducing—since cancer cells may produce too much of certain proteins or stop them from functioning correctly.
These insights allow for highly specific interventions like targeted cancer drugs and immunotherapy. For example, targeted drugs work by attacking the specific differences that help a cancer cell survive. Conversely, personalized medicine also serves as a safety tool; for instance, doctors test for DPD enzyme levels before using certain chemotherapies to prevent life-threatening side effects caused by drug buildup. While it offers immense promise, researchers are currently working to ensure these genomic systems are equitable and do not entrench biases against underrepresented populations.
The field is also evolving through 'stratified medicine,' which groups people based on shared genetic changes to find effective treatments for large subsets of patients. This progression from broad categories toward individual molecular profiles represents a fundamental shift in how we engineer better medicines.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Personalised medicine
- Also: Personalized medicine | Definition, Origins, Examples, & Ethical Considerations | Britannica
- Also: Personalized medicine
To cite this card, link to https://intellectplus.co.uk/app/health-personalized-medicine.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Eyes & vision · More in Health · Latest · A–Z · All topics
